Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes (Q35216433)

7 August 2017

1 reference

title

Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes (English)

1 reference

7 August 2017

0 references

1

Richard S Jope

1 reference

7 August 2017

publication date

1 September 2003

1 reference

Trends in Pharmacological Sciences

7 August 2017

published in

1 reference

7 August 2017

volume

24

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

441-443

1 reference

Anti-bipolar therapy: mechanism of action of lithium

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Molecular targets of lithium action

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

A molecular mechanism for the effect of lithium on development

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

The renaissance of GSK3

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Tau, where are we now?

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Neuroprotective effects of lithium in cultured cells and animal models of diseases.

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Lithium ameliorates HIV-gp120-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1).

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

1 reference

https://api.crossref.org/works/10.1016/S0165-6147(03)00206-2

7 January 2021

10.1016/S0165-6147(03)00206-2

Identifiers

DOI

1 reference

7 August 2017

1 reference